Cargando…
The Tissue Selective Estrogen Complex: A Promising New Menopausal Therapy
Menopause is associated with health concerns including vasomotor symptoms, vulvar/vaginal atrophy (VVA), and osteoporosis. Estrogen therapy or combined estrogen-progestin therapy (EPT) are primary treatment options for menopausal symptom relief and osteoporosis prevention. Because EPT has been assoc...
Autores principales: | Komm, Barry S., Mirkin, Sebastian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3816651/ https://www.ncbi.nlm.nih.gov/pubmed/24280697 http://dx.doi.org/10.3390/ph5090899 |
Ejemplares similares
-
Incorporating bazedoxifene/conjugated estrogens into the current paradigm of menopausal therapy
por: Komm, Barry S, et al.
Publicado: (2012) -
Breast-related effects of selective estrogen receptor modulators and tissue-selective estrogen complexes
por: Smith, Carolyn L, et al.
Publicado: (2014) -
The Tissue-Selective Estrogen Complex (Bazedoxifene/Conjugated Estrogens) for the Treatment of Menopause
por: Lello, Stefano, et al.
Publicado: (2017) -
Management of osteoporosis and menopausal symptoms: focus on bazedoxifene/conjugated estrogen combination
por: Mirkin, Sebastian, et al.
Publicado: (2013) -
Patient considerations in the management of menopausal symptoms: role of conjugated estrogens with bazedoxifene
por: Kagan, Risa, et al.
Publicado: (2016)